See Full Report below….
About Broad Street Alerts:
Big opportunities in Small Cap’s
Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our
Members in the last 3 small cap alerts alone!
February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our members gains- 83%
March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.
March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49%
For our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.
We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time.
We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
The stock of PharmAthene, Inc. (NYSEMKT:PIP) hit a new 52-week high and has $3.91 target or 89.00% above today’s $2.07 share price. The 8 months bullish chart indicates low risk for the $140.07M company. The 1-year high was reported on Apr, 4 by Barchart.com. If the $3.91 price target is reached, the company will be worth $124.66 million more. The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock is up 4.55% or $0.09 after the news, hitting $2.07 per share. About 258,995 shares traded hands or 98.37% up from the average. PharmAthene, Inc. (NYSEMKT:PIP) has risen 42.03% since August 26, 2015 and is uptrending. It has outperformed by 35.21% the S&P500.
According to Zacks Investment Research, “PharmAthene Inc. is a biodefense company formed to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene’s lead programs include Valortim and Protexia.”
Source: Stock Caller
Broad Street Alerts has not been compensated for the mention of __(NYSEMKT; PIP)_ and we do not hold any positions.